Bhamidipati Venkat sold (to issuer) $394K of CCRN
Bhamidipati Venkat sold (to issuer) 29,759 shares of CROSS COUNTRY HEALTHCARE INC (CCRN) at $13.25 ($0.39M total) on 2026-07-21.
How this was made
The 30-second read
Why it matters
The newest fact is the director’s sale of 29,759 shares at $13.25 on 2026-07-21, totaling about $394.3K, with holdings reduced to 0 shares.
Market read
Traders may note the insider sale, but there is no accompanying fundamental or regulatory news to drive a durable repricing.
What to watch
Insider sales can be driven by liquidity needs, diversification, or mechanical buyback participation; the filing provides no rationale or linkage to company performance.
Background
The article is an SEC Form 4 insider transaction disclosure for Cross Country Healthcare (CCRN).
Ticker impact
Form 4 shows director Bhamidipati Venkat sold 29,759 shares of Cross Country Healthcare at $13.25 on 2026-07-21, leaving 0 shares.
Low likelihood of a sustained price move based solely on this Form 4; any reaction would be sentiment-driven and short-lived.
The filing is a disclosed insider transaction, but it does not include new operating results, guidance, or regulatory/legal developments. Sale-to-issuer codes often relate to structured programs, reducing interpretive value.
Market effects
Minimal. This is company-specific insider transaction data with no sector-wide catalyst.
None indicated.
None indicated.
Counterpoint
If the sale-to-issuer code reflects a non-routine buyback participation, the absence of a 10b5-1 plan could be interpreted as less programmatic and therefore slightly more informative.
Key entities
- issuerCROSS COUNTRY HEALTHCARE INC
Company whose director insider transaction is disclosed on Form 4.
- insiderBhamidipati Venkat
Director who sold shares to the issuer on 2026-07-21.